Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV- inactivated, recombinant EBNA-3A vaccinia virus

Blood

Volumn 94, Issue 4, 1999, Pages 1372-1381

  Subklewe, Marion ^a   Chahroudi, Ann ^b   Schmaljohn, Alan ^b   Kurilla, Michael G ^b   Bhardwaj, Nina ^b   Steinman, Ralph M ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; INFECTION RESISTANCE; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS INFECTION;

EID: 0033566921     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.4.1372     Document Type: Article

References (53)

1. Klein G: Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77:791, 1994
2. Rickinson AB, Moss DJ: Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15:405, 1997
3. Deeg HJ, Socié G: Malignancies after hematopoietic stem cell transplantation: Many questions, some answers. Blood 91:1833, 1998
4. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V, Freese UK: Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med 313:1564, 1985
5. Papadopoulos EB, Ladanyi M, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina HC, Childs BH, Gillio AP, Small TN, Young JW, Kernan NA, O'Reilly RJ: Infusion of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330:1185, 1994
6. Rooney CM, Smith CA, Ng CYC, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9, 1995
7. Heslop HE, Ng CYC, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM: Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 2:551, 1996
8. Rooney CM, Smith CA, Ng CYC, Loftin SK, Sixbey JW, Gan Y, Srivastava D-K, Bowman LC, Krance RA, Brenner MK, Heslop HE: Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92:1549, 1998
9. Hart DNJ: Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 90:3245, 1997
10. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245, 1998
11. Porgador A, Snyder D, Gilboa E: Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 156:2918, 1996
12. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ: Therapy of murine tumors with tumor peptide pulsed dendritic cells: Dependence on T-cells, B7 costimulation, and Th1-associated cytokines. J Exp Med 183:87, 1996
13. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo Jr. LD: Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 183:283, 1996
14. Specht JM, Wang G, Do MT, Lam JS, Royal RE, Reeves ME, Rosenberg SA, Hwu P: Dendritic cells retrovirally transduced with a model tumor antigen gene are therapeutically effective against established pulmonary metastases. J Exp Med 186:1213, 1997
15. Song W, Kong H, Carpenter H, Torii H, Granstein R, Rafii S, Moore MAS, Crystal RG: Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model tumor antigen induce protective and therapeutic antitumor immunity. J Exp Med 186:1247, 1997
16. Mackey MF, Gunn JR, Maliszewski C, Kikutani H, Noelle RJ, Barth RJJ: Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol 161:2094, 1998
17. DeMatos P, Abdel-Wahab Z, Vervaert C, Seigler HF: Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice. Cell Immunol 185:65, 1998
18. Fields RC, Shimizu K, Mule JJ: Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci USA 95:9482, 1998
19. Ludewig B, Ehl S, Karrer U, Odermatt B, Hengartner H, Zinkernagel RM: Dendritic cells efficiently induce protective antiviral immunity. J Virol 272:3812, 1998
20. Su H, Messer R, Whitmire W, Fischer E, Portis JC, Caldwell HD: Vaccination against chlamydial genital tract infection following immu-nization with dendritic cells pulsed ex vivo with non-viable chlamydiae. J Exp Med 188:809, 1998
21. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB: Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies. J Exp Med 176:157, 1992
22. Steven NM, Leese AM, Annels NE, Lee SP, Rickinson AB: Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory. J Exp Med 184:1801, 1996
23. Callan MFC, Tan L, Annels N, Ogg GS, Wilson JDK, O'Callaghan CA, Steven N, McMichael AJ, Rickinson AB: Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 187:1395, 1998
24. Thomas JA, Hotchin N, Allday MJ, Yacoub M, Crawford DH: Immunohistology of Epstein-Barr virus associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49: 944, 1990
25. Gratama JW, Zutter MM, Minarovits J, Oosterveer MAP, Thomas ED, Klein G, Ernberg I: Expression of Epstein-Barr virus growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int J Cancer 188, 1991
26. Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E, Rickinson AB: Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc Natl Acad Sci USA 87:2906, 1990
27. Bhardwaj N, Young JW, Nisanian AJ, Baggers J, Steinman RM: Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J Exp Med 178:633, 1993
28. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N: Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196:121, 1996
29. Romani N, Reider D, HeuerM, Ebner S, Eibl B, Niederwieser D, Schuler G: Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability. J Immunol Methods 196:137, 1996
30. Reddy A, Sapp M, Feldman M, Subklewe M, Bhardwaj N: A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells. Blood 90:3640, 1997
31. Smith GL, Levin JZ, Palese P, Moss B: Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 160:336, 1987
32. Tsung K, Yim JH, Marti W, Buller RML, Norton JA: Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. J Virol 70:165, 1996
33. Rowe M, Evans HS, Young LS, Hennessey K, Kieff E, Rickinson AB: Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Virol 68:1575, 1987
34. Hill AB, Lee SP, Haurum JS, Murray N, Yao Q-Y, Rowe M, Signoret N, Rickinson AB, McMichael AJ: Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus [EBV] nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid cell lines against which they were raised. J Exp Med 181:2221, 1995
35. Shi Y, Smith KD, Kurilla MG, Lutz CT: Cytotoxic CD8+ Tcells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts. J Immunol 159:1844, 1997
36. Apollini A, Moss D, Stumm R, Burrows S, Suhrbier A, Misko I, Schmidt C, Sculley T: Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus. Eur J Immunol 22:183, 1992
37. Engelmayer J, Larsson M, Subklewe M, Chahroudi A, Schmaljohn A, William C, Steinman RM, Bhardwaj N: Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion, (submitted)
38. Albert ML, Sauter B, Bhardwaj N: Dendritic cells acquire antigen from apoptotic cells and induce class !-restricted CTLs. Nature 392:86, 1998
39. Young JW, Steinman RM: Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helperT cells. J Exp Med 171:1315, 1990
40. Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM: Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells. J Clin Invest 94:797, 1994
41. Misko IS, Schmidt C, Honeyman M, Soszynski TD, Sculley TB, Burrows SR, Moss DJ, Burman K: Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen. Clin Exp Immunol 87:65, 1992
42. Roskrow MA, Suzuki N, Gan Y-j, Sixbey JW, Ng CYC, Kimbrough S, Hudson M, Brenner MK, Heslop HE, Rooney CM: Epstein-Barr Virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood 91:2925, 1998
43. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR: Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333:1038, 1995
44. Brossart P, Goldrath AW, Butz EA, Martin S, Bevan MJ: Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J Immunol 158:3270, 1997
45. Fan Z, Huang XL, Zheng L, Wilson C, Borowski L, Liebmann J, Gupta P, Margolick J, Rinaldo C: Cultured blood dendritic cells retain HFV-1 antigen-presenting capacity for memory CTL during progressive HTV-1 infection. J Immunol 159:4973, 1997
46. Bronte V, Carroll MW, Goletz TJ, Overwijk WW, Marincola F, Rosenberg SA, Moss B, Restifo NP: Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc Natl Acad Sci USA 94:3183, 1997
47. Broder CC, Kennedy PE, Michaels F, Berguer EA: Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors. Gene 142:167, 1994
48. Brown CK, Turner PC, Moyer RW: Molecular characterization of the vaccinia virus hemagglutinin gene. J Virol 65:3598, 1991
49. Niles EG, Seto J: Vaccinia virus gene D8 encodes a virion transmembrane protein. J Virol 62:3772, 1988
50. Kibler KV, Shors T, Perkins KB, Zeman CC, Banaszak MP, Biesterfeldt J, Langland JO, Jacobs BL: Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J Virol 71:1992, 1997
51. Hanafusa H: Killing of L-cells by heat-and UV-inactivated vaccinia virus. Biken J 3:191, 1960
52. Grunwald-Beard L, Gamliel H, Parag G, Vedantham S, Zakay-Rones Z: Killing of Burkitt-lymphoma-derived Daudi cells by ultra-violet-inactivated vaccinia virus. J Cancer Res Clin Oncol 117:561, 1991
53. Bender A, Bui LK, Feldman MAV, Larsson M, Bhardwaj N: Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J Exp Med 182:1663, 1995